DUSA Pharmaceuticals
| Company type | Subsidiary |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 1991 |
| Founder | Rick Lufkin |
| Defunct | 2012 |
| Fate | Acquired |
| Successor | DUSA Dermatology |
| Headquarters | , |
Area served | United States |
| Products | Dermatological pharmaceuticals and treatments |
| Owner | Sun Pharma |
| Website | www |
DUSA Pharmaceuticals was an American pharmaceutical company with dermatology products, including Levulan and Nicomide. It was acquired by Sun Pharma in 2012 and the brand continues as DUSA Dermatology within the Sun Pharma company.
History
[edit]In the first quarter of 2006, DUSA Pharmaceuticals obtained Sirius Laboratories in a merger estimated to be worth 30 million dollars. Sirius was a privately held dermatology specialty pharmaceuticals company founded by Dr. Joel E. Bernstein in 2000 dedicated to the treatment of acne vulgaris and acne rosacea.[1]
In 2012, Caraco Pharmaceutical Laboratories (CPL), a subsidiary of Sun Pharmaceutical, acquired DUSA.[2][3]
References
[edit]- ^ "DUSA Pharmaceuticals Closes Acquisition of Sirius Laboratories". BNET. 2006-04-14. Retrieved 2008-08-26.
- ^ "Offer to purchase for cash all outstanding Shares of Common Stock of DUSA PHARMACEUTICALS, INC". US Securities and Exchange commission. December 19, 2012.
- ^ "Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSA". December 20, 2012. Archived from the original on 2015-09-12.